Astrana Health (ASTH) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Astrana Health (ASTH) last issued guidance on August 6, 2026 for Q3 2026. The company guided revenue in the range of $1B - $1.03B for the period.
Compared to prior guidance, Astrana Health lowered its revenue forecast from a prior range of $3.8B - $4.1B.
Astrana Health has issued 20 guidance updates between February 27, 2024 and August 6, 2026. During this period, the company raised its outlook 4 times and lowered it 7 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.65 | $0.58 | $0.26 | $0.55 |
| Actual | $0.40 | $0.29 | $0.12 | $0.01 |
| Surprise | -38.5% | -50.0% | -53.8% | -98.2% |
| Revenue | ||||
| Estimate | $984.4M | $946.3M | $927.8M | $951.8M |
| Actual | $972.5M | $965.1M | $950.5M | $956.0M |
| Surprise | -1.21% | +1.99% | +2.45% | +0.45% |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $0.77 | $0.55 |
| Revenue | ||
| Consensus | $1.02B | $1.02B |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $0.40 | $0.65 | -38.5 % |
| Q1 | May 7, 2026 | $0.29 | $0.58 | -50.0 % |
| Q4 | Mar 2, 2026 | $0.12 | $0.26 | -53.8 % |
| Q3 | Nov 6, 2025 | $0.01 | $0.55 | -98.2 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $972.52M | $984.45M | -1.21 % |
| Q1 | May 7, 2026 | $965.10M | $946.28M | 1.99 % |
| Q4 | Mar 2, 2026 | $950.53M | $927.81M | 2.45 % |
| Q3 | Nov 6, 2025 | $956.05M | $951.80M | 0.45 % |